Abstract
Summary
LPI (LP Information)' newest research report, the “Point-of-Care Testing Device Industry Forecast” looks at past sales and reviews total world Point-of-Care Testing Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Point-of-Care Testing Device sales for 2025 through 2031. With Point-of-Care Testing Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-Care Testing Device industry.
This Insight Report provides a comprehensive analysis of the global Point-of-Care Testing Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-Care Testing Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-Care Testing Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-Care Testing Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-Care Testing Device.
The global Point-of-Care Testing Device market size is projected to grow from US$ million in 2024 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
United States market for Point-of-Care Testing Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Point-of-Care Testing Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Point-of-Care Testing Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Point-of-Care Testing Device players cover Roche Holding, Abaxis, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer, HemoCue, International Technidyne Corporation and LifeScan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-Care Testing Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Troponin Test
Brain Natriuretic Peptide Test
Others
Segmentation by application
Clinics
Hospitals
Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Holding
Abaxis
Abbott
Beckman Coulter
Beckton and Dickinson
Bayer
HemoCue
International Technidyne Corporation
LifeScan
Nipro Diagnostics
Orasure Technologies
PointCare Technologies
Siemens
Key Questions Addressed in this Report
What is the 10-year outlook for the global Point-of-Care Testing Device market?
What factors are driving Point-of-Care Testing Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-Care Testing Device market opportunities vary by end market size?
How does Point-of-Care Testing Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Point-of-Care Testing Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-Care Testing Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-Care Testing Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-Care Testing Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-Care Testing Device.
The global Point-of-Care Testing Device market size is projected to grow from US$ million in 2024 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
United States market for Point-of-Care Testing Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Point-of-Care Testing Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Point-of-Care Testing Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Point-of-Care Testing Device players cover Roche Holding, Abaxis, Abbott, Beckman Coulter, Beckton and Dickinson, Bayer, HemoCue, International Technidyne Corporation and LifeScan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-Care Testing Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Troponin Test
Brain Natriuretic Peptide Test
Others
Segmentation by application
Clinics
Hospitals
Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Holding
Abaxis
Abbott
Beckman Coulter
Beckton and Dickinson
Bayer
HemoCue
International Technidyne Corporation
LifeScan
Nipro Diagnostics
Orasure Technologies
PointCare Technologies
Siemens
Key Questions Addressed in this Report
What is the 10-year outlook for the global Point-of-Care Testing Device market?
What factors are driving Point-of-Care Testing Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-Care Testing Device market opportunities vary by end market size?
How does Point-of-Care Testing Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point-of-Care Testing Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Point-of-Care Testing Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Point-of-Care Testing Device by Country/Region, 2020, 2024 & 2031
2.2 Point-of-Care Testing Device Segment by Type
2.2.1 Troponin Test
2.2.2 Brain Natriuretic Peptide Test
2.2.3 Others
2.3 Point-of-Care Testing Device Sales by Type
2.3.1 Global Point-of-Care Testing Device Sales Market Share by Type (2020-2025)
2.3.2 Global Point-of-Care Testing Device Revenue and Market Share by Type (2020-2025)
2.3.3 Global Point-of-Care Testing Device Sale Price by Type (2020-2025)
2.4 Point-of-Care Testing Device Segment by Application
2.4.1 Clinics
2.4.2 Hospitals
2.4.3 Laboratories
2.4.4 Others
2.5 Point-of-Care Testing Device Sales by Application
2.5.1 Global Point-of-Care Testing Device Sale Market Share by Application (2020-2025)
2.5.2 Global Point-of-Care Testing Device Revenue and Market Share by Application (2020-2025)
2.5.3 Global Point-of-Care Testing Device Sale Price by Application (2020-2025)
3 Global Point-of-Care Testing Device by Company
3.1 Global Point-of-Care Testing Device Breakdown Data by Company
3.1.1 Global Point-of-Care Testing Device Annual Sales by Company (2020-2025)
3.1.2 Global Point-of-Care Testing Device Sales Market Share by Company (2020-2025)
3.2 Global Point-of-Care Testing Device Annual Revenue by Company (2020-2025)
3.2.1 Global Point-of-Care Testing Device Revenue by Company (2020-2025)
3.2.2 Global Point-of-Care Testing Device Revenue Market Share by Company (2020-2025)
3.3 Global Point-of-Care Testing Device Sale Price by Company
3.4 Key Manufacturers Point-of-Care Testing Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-Care Testing Device Product Location Distribution
3.4.2 Players Point-of-Care Testing Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Point-of-Care Testing Device by Geographic Region
4.1 World Historic Point-of-Care Testing Device Market Size by Geographic Region (2020-2025)
4.1.1 Global Point-of-Care Testing Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Point-of-Care Testing Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Point-of-Care Testing Device Market Size by Country/Region (2020-2025)
4.2.1 Global Point-of-Care Testing Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Point-of-Care Testing Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Point-of-Care Testing Device Sales Growth
4.4 APAC Point-of-Care Testing Device Sales Growth
4.5 Europe Point-of-Care Testing Device Sales Growth
4.6 Middle East & Africa Point-of-Care Testing Device Sales Growth
5 Americas
5.1 Americas Point-of-Care Testing Device Sales by Country
5.1.1 Americas Point-of-Care Testing Device Sales by Country (2020-2025)
5.1.2 Americas Point-of-Care Testing Device Revenue by Country (2020-2025)
5.2 Americas Point-of-Care Testing Device Sales by Type
5.3 Americas Point-of-Care Testing Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-Care Testing Device Sales by Region
6.1.1 APAC Point-of-Care Testing Device Sales by Region (2020-2025)
6.1.2 APAC Point-of-Care Testing Device Revenue by Region (2020-2025)
6.2 APAC Point-of-Care Testing Device Sales by Type
6.3 APAC Point-of-Care Testing Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Point-of-Care Testing Device by Country
7.1.1 Europe Point-of-Care Testing Device Sales by Country (2020-2025)
7.1.2 Europe Point-of-Care Testing Device Revenue by Country (2020-2025)
7.2 Europe Point-of-Care Testing Device Sales by Type
7.3 Europe Point-of-Care Testing Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point-of-Care Testing Device by Country
8.1.1 Middle East & Africa Point-of-Care Testing Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Point-of-Care Testing Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Point-of-Care Testing Device Sales by Type
8.3 Middle East & Africa Point-of-Care Testing Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-Care Testing Device
10.3 Manufacturing Process Analysis of Point-of-Care Testing Device
10.4 Industry Chain Structure of Point-of-Care Testing Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-Care Testing Device Distributors
11.3 Point-of-Care Testing Device Customer
12 World Forecast Review for Point-of-Care Testing Device by Geographic Region
12.1 Global Point-of-Care Testing Device Market Size Forecast by Region
12.1.1 Global Point-of-Care Testing Device Forecast by Region (2026-2031)
12.1.2 Global Point-of-Care Testing Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-of-Care Testing Device Forecast by Type
12.7 Global Point-of-Care Testing Device Forecast by Application
13 Key Players Analysis
13.1 Roche Holding
13.1.1 Roche Holding Company Information
13.1.2 Roche Holding Point-of-Care Testing Device Product Portfolios and Specifications
13.1.3 Roche Holding Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Holding Main Business Overview
13.1.5 Roche Holding Latest Developments
13.2 Abaxis
13.2.1 Abaxis Company Information
13.2.2 Abaxis Point-of-Care Testing Device Product Portfolios and Specifications
13.2.3 Abaxis Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Abaxis Main Business Overview
13.2.5 Abaxis Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Point-of-Care Testing Device Product Portfolios and Specifications
13.3.3 Abbott Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Beckman Coulter
13.4.1 Beckman Coulter Company Information
13.4.2 Beckman Coulter Point-of-Care Testing Device Product Portfolios and Specifications
13.4.3 Beckman Coulter Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Beckman Coulter Main Business Overview
13.4.5 Beckman Coulter Latest Developments
13.5 Beckton and Dickinson
13.5.1 Beckton and Dickinson Company Information
13.5.2 Beckton and Dickinson Point-of-Care Testing Device Product Portfolios and Specifications
13.5.3 Beckton and Dickinson Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Beckton and Dickinson Main Business Overview
13.5.5 Beckton and Dickinson Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Point-of-Care Testing Device Product Portfolios and Specifications
13.6.3 Bayer Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 HemoCue
13.7.1 HemoCue Company Information
13.7.2 HemoCue Point-of-Care Testing Device Product Portfolios and Specifications
13.7.3 HemoCue Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 HemoCue Main Business Overview
13.7.5 HemoCue Latest Developments
13.8 International Technidyne Corporation
13.8.1 International Technidyne Corporation Company Information
13.8.2 International Technidyne Corporation Point-of-Care Testing Device Product Portfolios and Specifications
13.8.3 International Technidyne Corporation Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 International Technidyne Corporation Main Business Overview
13.8.5 International Technidyne Corporation Latest Developments
13.9 LifeScan
13.9.1 LifeScan Company Information
13.9.2 LifeScan Point-of-Care Testing Device Product Portfolios and Specifications
13.9.3 LifeScan Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 LifeScan Main Business Overview
13.9.5 LifeScan Latest Developments
13.10 Nipro Diagnostics
13.10.1 Nipro Diagnostics Company Information
13.10.2 Nipro Diagnostics Point-of-Care Testing Device Product Portfolios and Specifications
13.10.3 Nipro Diagnostics Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Nipro Diagnostics Main Business Overview
13.10.5 Nipro Diagnostics Latest Developments
13.11 Orasure Technologies
13.11.1 Orasure Technologies Company Information
13.11.2 Orasure Technologies Point-of-Care Testing Device Product Portfolios and Specifications
13.11.3 Orasure Technologies Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Orasure Technologies Main Business Overview
13.11.5 Orasure Technologies Latest Developments
13.12 PointCare Technologies
13.12.1 PointCare Technologies Company Information
13.12.2 PointCare Technologies Point-of-Care Testing Device Product Portfolios and Specifications
13.12.3 PointCare Technologies Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 PointCare Technologies Main Business Overview
13.12.5 PointCare Technologies Latest Developments
13.13 Siemens
13.13.1 Siemens Company Information
13.13.2 Siemens Point-of-Care Testing Device Product Portfolios and Specifications
13.13.3 Siemens Point-of-Care Testing Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Siemens Main Business Overview
13.13.5 Siemens Latest Developments
14 Research Findings and Conclusion